The Sickle Cell Clinical Trials Network: One Year In
The Hematologist Editor-in-Chief, Dr. Laura Michaelis, spoke with Drs. Charles Abrams and Sophie Lanzkron about a groundbreaking ASH initiative started approximate
Is Double-hit Diffuse Large B-cell Lymphoma More Common Than We Think?
Dr. Kahl studies the biologic underpinnings of a new entity that does not meet the classical definition of double-hit (DH) DLBCL but has gene expression signatures and clin
Expert opinion focused on challenging diagnostic and management issues
Dr. Daniel Lenihan discusses whether ibrutinib therapy can increase the risk of serious rhythm disturbances.
Dr. Gary Lyman examines the safety and efficacy of biosimilars approved by the U.S. Food and Drug Administration.
Dr. Kahn provides advice on recruiting and inspiring residents to subspecialize and become hematologists.
Dr. D'Souza provides insight into her approach to the diagnosis and management of monoclonal gammopathy of renal significance (MGRS).
Drs. Pemmaraju and Konopleva share their expertise treating blastic plasmacytoid dendritic cell neoplasm.
Dr. Sweet presents the case of a 48-year-old woman with chronic-phase chronic myeloid leukemia being treated effectively with imatinib, and contemplates whether the patient is a candidate for a trial of tyrosine kinase inhibitor cessation.
Dr. Lazarus and Dr. Ljungman discuss the optimal approach to prevent cytomegalovirus infection in patients undergoing allogeneic hematopoietic cell transplantation in 2018.
Dr. Lisa Baumann Kreuziger recommends an approach to antithrombotic therapy management in adults undergoing left ventricular assist device placement.
Drs. Miles Conrad, Melissa Dickey, Steven Hetts and Andrew Leavitt discuss approaches to hereditary hemorrhagic telangiectasia.
Drs. Andrea Baines and Ann Farrell explain the process of obtaining an investigational agent outside of a clinical trial through expanded access programs.
July-August 2019Volume 16, Issue 4
A new Compendium providing updated clinical information to "Ask the Hematologist" articles published in The Hematologist from 2010 to 2015 is now available.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology